Total Payments
$979.69
2024 Payments
$296.78
Companies
14
Transactions
39
Medicare Patients
9,697
Medicare Billing
$587,304
Payment Breakdown by Category
Food & Beverage$979.69 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $979.69 | 39 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic Vascular, Inc. | $198.53 | 5 | $0 (2019) |
| ABIOMED | $186.01 | 2 | $0 (2024) |
| Boston Scientific Corporation | $155.34 | 8 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $82.37 | 4 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $77.93 | 4 | $0 (2024) |
| PFIZER INC. | $60.70 | 3 | $0 (2024) |
| Abbott Laboratories | $48.05 | 3 | $0 (2023) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $39.14 | 2 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $30.39 | 2 | $0 (2024) |
| BIOTRONIK INC. | $27.88 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $296.78 | 8 | ABIOMED ($186.01) |
| 2023 | $163.65 | 8 | PFIZER INC. ($44.18) |
| 2022 | $83.61 | 4 | BIOTRONIK INC. ($27.88) |
| 2021 | $29.76 | 2 | Novartis Pharmaceuticals Corporation ($29.76) |
| 2019 | $73.95 | 5 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($19.92) |
| 2018 | $145.74 | 7 | BOSTON SCIENTIFIC CORPORATION ($65.34) |
| 2017 | $186.20 | 5 | Medtronic Vascular, Inc. ($124.80) |
All Payment Transactions
39 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/27/2024 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $57.57 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/21/2024 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $128.44 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/09/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 02/05/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.41 | General |
| Category: Cardiovascular | ||||||
| 02/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: DIABETES | ||||||
| 01/23/2024 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/20/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/16/2023 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/30/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $28.58 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/12/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: DIABETES | ||||||
| 04/04/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $19.22 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 03/29/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: DIABETES | ||||||
| 02/28/2023 | PFIZER INC. | VYNDAQEL (Drug), COMIRNATY | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/12/2023 | Abbott Laboratories | JOT DX (Device) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/15/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: DIABETES | ||||||
| 10/21/2022 | Lantheus Medical Imaging, Inc. | DEFINITY (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: CONTRAST AGENT | ||||||
| 07/23/2022 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: WATCHMAN_IC | ||||||
| 01/14/2022 | BIOTRONIK INC. | Rivacor 7 DR-T (Device), Edora 8 DR-T, BIOMONITOR | Food and Beverage | In-kind items and services | $27.88 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/21/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/14/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $12.45 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/23/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/29/2019 | Abbott Laboratories | HeartMate (Device) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 08/15/2019 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $19.92 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 2,774 | 4,630 | $539,870 | $140,640 |
| 2022 | 19 | 2,132 | 3,775 | $440,115 | $135,420 |
| 2021 | 31 | 2,461 | 4,395 | $521,913 | $172,436 |
| 2020 | 27 | 2,330 | 4,256 | $480,711 | $138,808 |
Total Patients
9,697
Total Services
17,056
Medicare Billing
$587,304
Procedure Codes
106
All Medicare Procedures & Services
106 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 334 | 474 | $93,018 | $44,107 | 47.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 362 | 374 | $140,624 | $19,501 | 13.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 126 | 263 | $33,065 | $17,222 | 52.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 901 | 1,430 | $78,650 | $9,240 | 11.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 68 | 71 | $16,138 | $7,614 | 47.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 363 | 576 | $43,440 | $6,433 | 14.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 43 | 48 | $11,669 | $6,264 | 53.7% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 63 | 156 | $14,820 | $3,524 | 23.8% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 74 | 185 | $17,575 | $3,252 | 18.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 43 | 43 | $7,426 | $3,175 | 42.8% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 33 | 358 | $12,530 | $3,097 | 24.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 17 | $4,975 | $2,443 | 49.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 17 | 23 | $3,350 | $2,268 | 67.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 37 | 37 | $12,576 | $2,058 | 16.4% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 15 | 64 | $4,182 | $1,912 | 45.7% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 15 | 64 | $2,856 | $1,283 | 44.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 11 | 11 | $2,085 | $1,047 | 50.2% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 55 | 58 | $4,350 | $1,031 | 23.7% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 13 | 31 | $5,735 | $866.70 | 15.1% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 47 | 48 | $8,400 | $764.58 | 9.1% |
| 85610 | Blood test, clotting time | Office | 2023 | 17 | 159 | $3,975 | $667.80 | 16.8% |
| 93350 | Ultrasound of heart during rest, exercise and/or drug-induced stress with report | Facility | 2023 | 12 | 13 | $3,360 | $628.33 | 18.7% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 12 | 14 | $1,370 | $577.50 | 42.2% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 12 | 27 | $1,890 | $532.25 | 28.2% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 47 | 48 | $8,400 | $506.35 | 6.0% |
About Dr. Christopher Oswald, MD
Dr. Christopher Oswald, MD is a Critical Care Medicine healthcare provider based in Pottstown, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1346236403.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Oswald, MD has received a total of $979.69 in payments from pharmaceutical and medical device companies, with $296.78 received in 2024. These payments were reported across 39 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($979.69).
As a Medicare-enrolled provider, Oswald has provided services to 9,697 Medicare beneficiaries, totaling 17,056 services with total Medicare billing of $587,304. Data is available for 4 years (2020–2023), covering 106 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Cardiovascular Disease
- Location Pottstown, PA
- Active Since 09/23/2005
- Last Updated 02/02/2024
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1346236403
Products in Payments
- Impella (Device) $186.01
- Micra (Device) $124.80
- JARDIANCE (Drug) $77.93
- Azure (Device) $61.77
- LEQVIO (Drug) $52.61
- VIGILANT (Device) $43.00
- LifeVest (Device) $39.14
- VYNDAQEL (Drug) $35.83
- BRILINTA (Drug) $30.39
- ENTRESTO (Drug) $29.76
- Rivacor 7 DR-T (Device) $27.88
- Corlanor (Drug) $26.16
- ELIQUIS (Drug) $24.87
- GENERAL THERAPIES (Device) $22.34
- WATCHMAN Access System (Device) $21.45
- WATCHMAN FLX (Device) $20.96
- GENERAL - THERAPIES (Device) $18.95
- Alere i (Device) $18.63
- GENERAL - TACHY (Device) $16.29
- DEFINITY (Drug) $16.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.